September 4, 2017
Novartis CEO Jimenez to retire after eight years
Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, step down as CEO in 2018, after eight years in position. To…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Vasant Narasimhan
December 16, 2016
Novartis buys Ziarco Group
Novartis has entered into a definitive agreement to buy a privately held company Ziarco Group Limited, focused on producing dermatology…
November 9, 2015
Cosentyx shows no further progression in joint damage in over 80% of PsA
Novartis has announced new results for Cosentyx (secukinumab) showing no further progression in joint damage in 84% of patients with…
October 1, 2015
Novartis Announces NEJM Publication of Secukinumab Phase III
Novartis announced on Wednesday that results from the pivotal Phase III FUTURE 1 study for Secukinumab in psoriatic arthritis (PsA)…